Based on your previous selection, you have been forwarded to the website for International.

Hello, This is our first page.

AbigailTest

Read About Our Amazing History

Timeline


Warning: Invalid argument supplied for foreach() in /var/www/metasystems/incoming/stag/processwire/www/site/templates/abigailtest.php on line 44
Image of Lilya Brik

Rodchenko's famous photo of Lilya Brik

Towards the end of the 1980s, the idea of automating microscopy emerged. A key step in cytogenetics and biodosimetry was, and still is, the search for metaphases (the stage of cell division at which chromosomes can be visualized under the microscope). This is a tedious procedure when performed manually. Our founder and CEO, Dr. Thomas Lörch, developed a system for the automated detection of metaphases as part of his doctoral thesis at the Institute of Applied Physics at the University of Heidelberg. He named the new system Metafer and founded MetaSystems in 1986.

Metafer gained more and more professional users and quickly became indispensable for them. As a complement for cytogenetics, we developed the interactive karyotyping software Ikaros in 1991. The success of Metafer and Ikaros led to a steady growth of the company, which is still completely independent from external investor.

Image of Lilya Brik

Rodchenko's famous photo of Lilya Brik

Towards the end of the 1980s, the idea of automating microscopy emerged. A key step in cytogenetics and biodosimetry was, and still is, the search for metaphases (the stage of cell division at which chromosomes can be visualized under the microscope). This is a tedious procedure when performed manually. Our founder and CEO, Dr. Thomas Lörch, developed a system for the automated detection of metaphases as part of his doctoral thesis at the Institute of Applied Physics at the University of Heidelberg. He named the new system Metafer and founded MetaSystems in 1986.

Metafer gained more and more professional users and quickly became indispensable for them. As a complement for cytogenetics, we developed the interactive karyotyping software Ikaros in 1991. The success of Metafer and Ikaros led to a steady growth of the company, which is still completely independent from external investor.

Image of Lilya Brik

Rodchenko's famous photo of Lilya Brik

Towards the end of the 1980s, the idea of automating microscopy emerged. A key step in cytogenetics and biodosimetry was, and still is, the search for metaphases (the stage of cell division at which chromosomes can be visualized under the microscope). This is a tedious procedure when performed manually. Our founder and CEO, Dr. Thomas Lörch, developed a system for the automated detection of metaphases as part of his doctoral thesis at the Institute of Applied Physics at the University of Heidelberg. He named the new system Metafer and founded MetaSystems in 1986.

Metafer gained more and more professional users and quickly became indispensable for them. As a complement for cytogenetics, we developed the interactive karyotyping software Ikaros in 1991. The success of Metafer and Ikaros led to a steady growth of the company, which is still completely independent from external investor.

Image of Lilya Brik

Rodchenko's famous photo of Lilya Brik

Towards the end of the 1980s, the idea of automating microscopy emerged. A key step in cytogenetics and biodosimetry was, and still is, the search for metaphases (the stage of cell division at which chromosomes can be visualized under the microscope). This is a tedious procedure when performed manually. Our founder and CEO, Dr. Thomas Lörch, developed a system for the automated detection of metaphases as part of his doctoral thesis at the Institute of Applied Physics at the University of Heidelberg. He named the new system Metafer and founded MetaSystems in 1986.

Metafer gained more and more professional users and quickly became indispensable for them. As a complement for cytogenetics, we developed the interactive karyotyping software Ikaros in 1991. The success of Metafer and Ikaros led to a steady growth of the company, which is still completely independent from external investor.

Image of Lilya Brik

Rodchenko's famous photo of Lilya Brik

Towards the end of the 1980s, the idea of automating microscopy emerged. A key step in cytogenetics and biodosimetry was, and still is, the search for metaphases (the stage of cell division at which chromosomes can be visualized under the microscope). This is a tedious procedure when performed manually. Our founder and CEO, Dr. Thomas Lörch, developed a system for the automated detection of metaphases as part of his doctoral thesis at the Institute of Applied Physics at the University of Heidelberg. He named the new system Metafer and founded MetaSystems in 1986.

Metafer gained more and more professional users and quickly became indispensable for them. As a complement for cytogenetics, we developed the interactive karyotyping software Ikaros in 1991. The success of Metafer and Ikaros led to a steady growth of the company, which is still completely independent from external investor.


Image of Lilya Brik

The future with MetaSystems

Tab 1 Text Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Image of Lilya Brik

The future with MetaSystems

Text Tab 2 Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Image of Lilya Brik

The future with MetaSystems

Test Tab 3 Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet.

Image of Lilya Brik

The future with MetaSystems

Towards the end of the 1980s, the idea of automating microscopy emerged. A key step in cytogenetics and biodosimetry was, and still is, the search for metaphases (the stage of cell division at which chromosomes can be visualized under the microscope). This is a tedious procedure when performed manually. Our founder and CEO, Dr. Thomas Lörch, developed a system for the automated detection of metaphases as part of his doctoral thesis at the Institute of Applied Physics at the University of Heidelberg. He named the new system Metafer and founded MetaSystems in 1986.

Metafer gained more and more professional users and quickly became indispensable for them. As a complement for cytogenetics, we developed the interactive karyotyping software Ikaros in 1991. The success of Metafer and Ikaros led to a steady growth of the company, which is still completely independent from external investor.

The future

Buy the best solutions

Towards the end of the 1980s, the idea of automating microscopy emerged. A key step in cytogenetics and biodosimetry was, and still is, the search for metaphases (the stage of cell division at which chromosomes can be visualized under the microscope). This is a tedious procedure when performed manually. Our founder and CEO, Dr. Thomas Lörch, developed a system for the automated detection of metaphases as part of his doctoral thesis at the Institute of Applied Physics at the University of Heidelberg. He named the new system Metafer and founded MetaSystems in 1986.

Metafer gained more and more professional users and quickly became indispensable for them. As a complement for cytogenetics, we developed the interactive karyotyping software Ikaros in 1991. The success of Metafer and Ikaros led to a steady growth of the company, which is still completely independent from external investor.

The future

Best quality

Towards the end of the 1980s, the idea of automating microscopy emerged. A key step in cytogenetics and biodosimetry was, and still is, the search for metaphases (the stage of cell division at which chromosomes can be visualized under the microscope). This is a tedious procedure when performed manually. Our founder and CEO, Dr. Thomas Lörch, developed a system for the automated detection of metaphases as part of his doctoral thesis at the Institute of Applied Physics at the University of Heidelberg. He named the new system Metafer and founded MetaSystems in 1986.

Metafer gained more and more professional users and quickly became indispensable for them. As a complement for cytogenetics, we developed the interactive karyotyping software Ikaros in 1991. The success of Metafer and Ikaros led to a steady growth of the company, which is still completely independent from external investor.

The future

Dataprotection guaranteed

Towards the end of the 1980s, the idea of automating microscopy emerged. A key step in cytogenetics and biodosimetry was, and still is, the search for metaphases (the stage of cell division at which chromosomes can be visualized under the microscope). This is a tedious procedure when performed manually. Our founder and CEO, Dr. Thomas Lörch, developed a system for the automated detection of metaphases as part of his doctoral thesis at the Institute of Applied Physics at the University of Heidelberg. He named the new system Metafer and founded MetaSystems in 1986.

Metafer gained more and more professional users and quickly became indispensable for them. As a complement for cytogenetics, we developed the interactive karyotyping software Ikaros in 1991. The success of Metafer and Ikaros led to a steady growth of the company, which is still completely independent from external investor.

The future

Ahead in robotics

Towards the end of the 1980s, the idea of automating microscopy emerged. A key step in cytogenetics and biodosimetry was, and still is, the search for metaphases (the stage of cell division at which chromosomes can be visualized under the microscope). This is a tedious procedure when performed manually. Our founder and CEO, Dr. Thomas Lörch, developed a system for the automated detection of metaphases as part of his doctoral thesis at the Institute of Applied Physics at the University of Heidelberg. He named the new system Metafer and founded MetaSystems in 1986.

Metafer gained more and more professional users and quickly became indispensable for them. As a complement for cytogenetics, we developed the interactive karyotyping software Ikaros in 1991. The success of Metafer and Ikaros led to a steady growth of the company, which is still completely independent from external investor.

The future

Advanced health solutions

Towards the end of the 1980s, the idea of automating microscopy emerged. A key step in cytogenetics and biodosimetry was, and still is, the search for metaphases (the stage of cell division at which chromosomes can be visualized under the microscope). This is a tedious procedure when performed manually. Our founder and CEO, Dr. Thomas Lörch, developed a system for the automated detection of metaphases as part of his doctoral thesis at the Institute of Applied Physics at the University of Heidelberg. He named the new system Metafer and founded MetaSystems in 1986.

Metafer gained more and more professional users and quickly became indispensable for them. As a complement for cytogenetics, we developed the interactive karyotyping software Ikaros in 1991. The success of Metafer and Ikaros led to a steady growth of the company, which is still completely independent from external investor.